Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12851387 | 0.78 | KCNN4 (0.34) | KCNN4DGAT1SRCTSHRMEN1 | |
| SCHEMBL2098303 | 0.78 | CYP4F2 (0.42) | ALDH1A1MEN1THRBKMT2AEGLN1 | |
| SCHEMBL115741 | 0.78 | FFAR3 (0.41) | ALDH1A1TSHRMEN1CYP1A2THRB | |
| SCHEMBL17763305 | 0.77 | FFAR3 (0.38) | ALDH1A1TSHRMEN1CYP1A2THRB | |
| SCHEMBL221073 | 0.77 | PTPN1 (0.40) | KCNN4DGAT1ALDH1A1POLBSRC | |
| SCHEMBL27968769 | 0.76 | MEN1 (0.41) | ALDH1A1TSHRMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL3267215 | 0.75 | FFAR3 (0.39) | ALDH1A1TSHRMEN1CYP1A2THRB | |
| Hydrochloric Acid SCHEMBL28434900 | 0.75 | FFAR3 (0.39) | ALDH1A1TSHRMEN1CYP1A2THRB | |
| SCHEMBL28419811 | 0.75 | FFAR3 (0.39) | ALDH1A1TSHRMEN1CYP1A2THRB | |
| Water SCHEMBL5129171 | 0.75 | FFAR3 (0.39) | ALDH1A1TSHRMEN1CYP1A2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372300-B2 | Additives for electrolyte solution and electrolyte solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2013-02-12 | — | — | US | claimed |
| EP-2037468-B1 | ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | OTSUKA CHEMICAL CO LTD (JP) | 2012-10-24 | — | — | EP | claimed |
| US-20120170172-A1 | ADDITIVES FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | OKA AKINORI (JP) | 2012-07-05 | — | — | US | claimed |
| US-8163195-B2 | Additives for electrolyte solution and electrolyte solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | claimed |
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-12-17 | — | — | US | claimed |
| EP-2037468-A1 | ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | Otsuka Chemical Co., Ltd. (JP) | 2009-03-18 | — | — | EP | claimed |
| US-8372300-B2 | Additives for electrolyte solution and electrolyte solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| EP-2037468-B1 | ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | OTSUKA CHEMICAL CO LTD (JP) | 2012-10-24 | — | — | EP | disclosed |
| US-20120170172-A1 | ADDITIVES FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | OKA AKINORI (JP) | 2012-07-05 | — | — | US | disclosed |
| US-8163195-B2 | Additives for electrolyte solution and electrolyte solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
| EP-2037468-A1 | ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | Otsuka Chemical Co., Ltd. (JP) | 2009-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | SLC9A1, SLC26A3, AQP1 | KCNN4 31/4885DGAT1 2888/4885ALDH1A1 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.